UPDATED Mar 27, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | kr1.44 | 5.7% | 19.7% | kr389.4m | kr1.80 | PS5.4x | E96.2% | n/a | Tech | ||
WAYS | kr20.90 | 5.6% | -67.5% | kr168.7m | kr39.75 | PS1.5x | E81.8% | 0% | Tech | ||
CHECK | kr36.90 | 3.9% | -9.8% | kr1.1b | kr62.00 | PE312x | E70.0% | n/a | Software | ||
TFBANK | kr166.60 | -1.4% | 28.0% | kr3.6b | kr203.33 | PB1.7x | E23.1% | n/a | Banks | ||
KAN | kr1.71 | -5.5% | -49.4% | kr139.7m | kr5.00 | PB2.9x | E131.9% | n/a | Pharmaceuticals & Biotech | ||
ENRAD | kr4.76 | 1.7% | 6.3% | kr116.2m | kr5.00 | PE2003.5x | E62.0% | n/a | Capital Goods | ||
CINIS | kr34.75 | 5.6% | -30.3% | kr2.5b | kr75.00 | PB6.2x | E77.3% | n/a | Materials | ||
DIGN | kr1.87 | -1.1% | -61.6% | kr131.8m | kr9.50 | PS1.5x | E139.0% | n/a | Healthcare | ||
CLBIO | kr11.95 | -2.0% | 30.2% | kr256.8m | kr32.00 | PS7.2x | E71.1% | n/a | Pharmaceuticals & Biotech | ||
YIELD | kr3.68 | 4.5% | -56.2% | kr197.1m | kr12.00 | PS1.1x | E88.5% | n/a | Diversified Financials | ||
W5 | kr75.80 | -12.5% | 4.6% | kr1.1b | kr110.00 | PS2.9x | E66.6% | n/a | Capital Goods | ||
HEXI | kr0.50 | 5.0% | -51.3% | kr180.3m | n/a | PS5.2x | E118.5% | n/a | Capital Goods | ||
SPAGO | kr0.29 | -0.7% | -62.3% | kr65.2m | n/a | PS11x | E56.0% | n/a | Pharmaceuticals & Biotech | ||
DVYSR | kr101.00 | 0.5% | 44.3% | kr1.6b | kr115.39 | PS9.7x | E99.3% | n/a | Pharmaceuticals & Biotech | ||
SKOLON | kr22.20 | 1.4% | -5.9% | kr589.3m | kr27.50 | PE76.7x | E54.0% | 2.5% | Software | ||
XBRANE | kr0.29 | -41.7% | -99.7% | kr8.6m | kr61.38 | PB0.05x | E126.0% | n/a | Pharmaceuticals & Biotech | ||
XMR | kr0.35 | 8.7% | -29.1% | kr36.6m | n/a | PS1.2x | E101.2% | n/a | Software | ||
BINV | kr16.84 | 3.8% | -41.6% | kr1.1b | kr108.50 | PS15.5x | E60.1% | n/a | Pharmaceuticals & Biotech | ||
EGTX | kr6.60 | -0.6% | 30.2% | kr1.9b | kr13.13 | PS33.5x | E85.4% | n/a | Pharmaceuticals & Biotech | ||
SUN4 | kr7.04 | -3.6% | -42.8% | kr114.6m | kr29.00 | PE14.3x | E49.6% | n/a | Capital Goods | ||
MAVEN | kr19.15 | 3.8% | 46.0% | kr993.2m | kr25.00 | PE27.2x | E45.9% | 0.5% | Tech | ||
BIOVIC B | kr2.48 | 0.4% | -72.1% | kr208.0m | kr15.00 | PS29.9x | E83.0% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | kr1.86 | 1.1% | -3.4% | kr200.6m | kr3.04 | PS2.5x | E77.4% | n/a | Tech | ||
PAX | kr36.30 | 5.2% | 8.4% | kr690.2m | kr80.00 | PE83.8x | E63.3% | n/a | Healthcare |